Treatment of MEC is complete surgical excision, using Mohs technique if necessary [4] . Local recurrences may occur after incomplete removal. We report a case of a primary cutaneous mucoepidermoid carcinoma, who presented with left upper eyelid mass.
Case Summary
A 79 year-old woman presented to the Ophthalmology clinics with a progressively growing mass on the left upper eyelid with ulcerated skin for the last 2 months. Physical examination showed an erythematous, well defined, ulcerated nodule on his left upper eyelid of size 2 x 2 cm ( Figure 1 ). No systemic symptoms were found but only cervical lymphadenopathy was present. Fine needle aspiration cytology revealed a necrotic and mucinous background with few dispersed atypical cells, suggestive of malignancy ( Figure 2 ). The mass was excised and grossly, showed a well encapsulated, grey, soft to cystic and mucoid tissue of 2.5 × 2.0 cm in size ( Figure 3) . 
Methods:
We report a case of MEC of the eyelid skin in a 79-yearold woman who presented with a soft to cystic mass on the left upper eyelid.
Results:
Microscopically it was characterized by a circumscribed, cystic neoplasm, with vague lobules of low-grade-appearing squamous cells accompanied by mucigenic and clear cells. A mucin stain highlighted the PAS positive mucigenic cells. Immunohistochemistry revealed pan-cytokeratin, cytokeratin 7, polyclonal carcinoembryonic antigen and epithelial membrane antigen positivity. The cytokeratin 20 and gross cystic disease fluid protein were nonreactive.
Conclusion:
Since the primary cutaneous mucoepidermoid carcinoma is an aggressive neoplasm that frequently develops metastases, it is important to distinguish it from primary MEC originating from the salivary glands for better management and suitable therapeutic decisions.
Keywords: Eyelid; Histopathology; Immunohistochemistry; Mucoepidermoid carcinoma; Mucin CEA and was negative for cytokeratin 20 and S100. The patient has no evidence of disease after 12 months of follow up period.
Discussion
Mucoepidermoid Carcinoma (MEC) is a relatively common neoplasm. Primary MEC accounts for approximately 30% of all malignant tumors arising in major and minor salivary glands [1, 2] . MEC was established as a unique salivary gland tumor in 1945 by Stewart et al., [4, 5] . It most commonly affects the salivary glands, especially the parotid but also submandibular and minor salivary glands. MEC is also found in the lacrimal gland, with an incidence of approximately 1.5-4% [3, 4] . It may rarely be reported in the esophagus, lung, bronchi, trachea, breast, thymus, thyroid, pancreas and female genital tract [3, [5] [6] [7] . Cutaneous involvement as a primary origin is extremely rare, with only 11 cases reported in the medical literature [4, 5] .
The lesion is often well circumscribed and partly cystic. It is deep in location and not attached to the epidermis [5] . The tumor is composed of three cell types: mucinous, squamous and clear. The squamous cells are in lobules and the mucigenic and clear cells are admixed [4] . Periodic Acid-Schiff stain highlights the mucigenic cells. Histologically MEC can be divided into low-grade (well-differentiated) and high-grade (poorly differentiated) subtypes, although an intermediate grade has also been proposed. Also three groups have been described based on the proportion of mucin-secreting, squamous, intermediate and clear cells and the degree of maturation of these cells [3, 7] .
MEC is often used synonymously with Adenosquamous Carcinoma (ASC). But ASC and its clinical behavior is quite different from MEC, especially in the case of a low-grade MEC, whether in the salivary gland or the skin [8, 9] . MEC is usually a low-grade neoplasm with limited metastatic potential, whereas Adenosquamous Carcinoma (ASC) is a high grade neoplasm prone to local recurrence and metastatic dissemination [9, 10] .
Quintas et al., performed two local excisions with adjuvant cryotherapy and mitomycin C application in their case of mucoepidermoid carcinoma of the bulbar conjunctiva over a period of 6 months [11] . Siuw et al., performed adjuvant radiotherapy in a case of secondary mucoepidermoid carcinoma of the orbit [12] .
Immunohistochemically, mucoepidermoid carcinomas are positive for CK7, Pan CK, EMA and CEA and negative for CK20 and anti-human gross cystic disease fluid protein [13, 14] . Primary mucoepidermoid carcinoma of the orbit is rare and typically arises from the lacrimal gland or sac. Those tumors not arising from lacrimal apparatus should be presumed metastatic in origin and the thorough systemic survey should be undertaken in the search for the primary tumor [12] . Rare cases of cutaneous metastasis of MEC originating from different sites, like the bronchi should be taken into account [3] . Yadav et al., reported a case of an exophytic lesion of the left bulbar conjunctiva following treatment for high grade mucoepidermoid cancer of ipsilateral parotid gland, 9 months back [15] . For this reason a careful evaluation of the patients to look for occult neoplasms in distant sites needs to be done. It is recommended to perform blood chemistry profile, complete blood count together with diagnostic imaging like total body Positron Emission Tomography and Computed Tomography Scan and p63 immunostaining to differentiate cutaneous metastasis from primary MEC [10, 15, 16] .
Conclusion
Primary MEC of the skin is usually a slow-growing neoplasm that should be differentiated from adenosquamous carcinoma and immunohistochemical staining for p63 is helpful to differentiate primary and metastatic MEC in the skin.
